Murat Cakir

Murat Cakir

Auto-generated profile, based on publicly available information

Murat Cakir

Department of Pediatric Gastroenterology Hepatology and Nutrition, Karadeniz Technical University, Faculty of Medicine, Trabzon, Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2007 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
MCMurat Cakir
Murat Cakir
IMIlke Mungan
Ilke Mungan
TKTaner Karakas
Taner Karakas
IGİlknur Girisken
İlknur Girisken
AOAysenur Okten
Aysenur Okten

19 April 2007 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
SASema Aydogdu
Sema Aydogdu
MCMurat Cakir
Murat Cakir
CAC. Arikan
C. Arikan
GTGokhan Tumgor
Gokhan Tumgor
HYHasan Ali Yuksekkaya
Hasan Ali Yuksekkaya
MKMurat Kilic
Murat Kilic

28 January 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DADenise Aldrian
Denise Aldrian
GVGeorg Friedrich Vogel
Georg Friedrich Vogel
TFTeresa K. Frey
Teresa K. Frey
HChasret ayyıldız civan
hasret ayyıldız civan
AAAysel Ünlüsoy Aksu
Aysel Ünlüsoy Aksu
Andreas R. JaneckeAndreas R. Janecke
Andreas R. Janecke
Myosin Vb (MYO5B) is a motor protein that facilitates protein trafficking and recycling in polarized cells by RAB11- and RAB8-dependent mechanisms. Biallelic MYO5B mutations are identified in the majority of patients with microvillus inclusion disease (MVID). MVID is an intractable diarrhea of infantile onset with characteristic histopathologic findings that requires life-long parenteral nutrition or intestinal transplantation. A large number of such patients eventually develop cholestatic liver disease. Bi-allelic MYO5B mutations are also identified in a subset of patients with predominant early-onset cholestatic liver disease. We present here the compilation of 114 patients with disease-causing MYO5B genotypes, including 44 novel patients as well as 35 novel MYO5B mutations, and an analysis of MYO5B mutations with regard to functional consequences. Our data support the concept that (1) a complete lack of MYO5B protein or early MYO5B truncation causes predominant intestinal disease (MYO5B-MVID), (2) the expression of full-length mutant MYO5B proteins with residual function causes predominant cholestatic liver disease (MYO5B-PFIC), and (3) the expression of mutant MYO5B proteins without residual function causes both intestinal and hepatic disease (MYO5B-MIXED). Genotype-phenotype data are deposited in the existing open MYO5B database in order to improve disease diagnosis, prognosis, and genetic counseling.

1 January 2008 in Scandinavian Journal of Gastroenterology
Verified
Journal Article
Closed access
SASema Aydogdu
Sema Aydogdu
MCMurat Cakir
Murat Cakir
HYHasan Ali Yuksekkaya
Hasan Ali Yuksekkaya
GTGokhan Tumgor
Gokhan Tumgor
MBMasallah Baran
Masallah Baran
RYRasit V. Yagci
Rasit V. Yagci
Objective. To analyze the prevalence of Helicobacter pylori (H. pylori) infection in children with celiac disease (CD) and to examine the role of H. pylori infection in clinical, laboratory and histopathological presentations of CD. Material and methods. Data on 96 children with CD and 235 children who underwent endoscopy were compared for the prevalence and gastric histology pattern of H. pylori. Clinical presentation, laboratory and histological findings of CD children with and without H. pylori infection were compared. Results. Twenty-one subjects (21.8%) in the CD group and 56 subjects (23.8%) in the control group had H. pylori gastritis. Gastric metaplasia is higher in CD patients with H. pylori gastritis (19%) than in patients without H. pylori gastritis (1.3%) and in the control group (3.5%) (p<0.05 for all groups). Abdominal distension is more common at initial admission in CD patients with H. pylori gastritis (57.1% versus 14.6%, p<0.05). No significant difference was found between H. pylori (+) and (−) CD patients in terms of prevalence of anemia, iron deficiency and iron-deficiency anemia. Only mild duodenal histological findings were more common in H. pylori patients (57.1% versus 26.7%, p<0.05). Conclusions. CD may be associated with H. pylori gastritis, but it does not affect the clinical presentation of the disease, except for abdominal distension; CD is associated with mild duodenal lesions. A gluten-free diet improves the symptoms in all patients independently of the presence of H. pylori gastritis. Gastric metaplasia increases in the presence of H. pylori gastritis. Further prospective studies are needed to examine the clinical and histopathological outcomes of gastric metaplasia associated with H. pylori gastritis in CD patients.

15 September 2017 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
MÇMurat Çakır
Murat Çakır
AİAyşe Aksel İşbilen
Ayşe Aksel İşbilen
IEİlKer Eyüpoğlu
İlKer Eyüpoğlu
ESElif Sağ
Elif Sağ
AÖAsım Örem
Asım Örem
GKGülay Kaya
Gülay Kaya
Background/Aims: We aimed to analyze the efficiency of a novel treatment approach, long-term synbiotic supplementation, in addition to lifestyle changes in children with non-alcoholic fatty liver disease (NAFLD). Materials and Methods: The study included children with NAFLD (n=28) and a healthy control group (n=30). Children with NAFLD were given 1 capsule/day of synbiotics. Anthropometric parameters; biochemical analysis, including ethanol, tumor necrosis factor-α (TNF-α), total oxidant status (TOS) and anti-oxidant status (TAS), zonulin, and fecal calprotectin; and ultrasonographic examination were performed at baseline and 4 months later. Results: The grade of fatty liver was decreased (≥1 grade) in 19 of the 28 patients (67.8%) after synbiotic supplementation. Total cholesterol, low-density lipoprotein (LDL) levels, TNF-α, C-reactive protein (CRP), and ethanol were significantly decreased, and TAS levels were significantly increased at the end of treatment (p Conclusion: Synbiotic supplementation in addition to lifestyle changes is effective in children with NAFLD. Cite this article as: Çakır M, İşbilen AA, Eyüpoğlu İ, et al. Effects of long-term synbiotic supplementation in addition to lifestyle changes in children with obesity-related non-alcoholic fatty liver disease. Turk J Gastroenterol 2017; 28: 377-83

30 January 2012 in Gut and Liver
Verified
Journal Article
Open access
PDF file
MCMurat Cakir
Murat Cakir
SKSuleyman Caner Karahan
Suleyman Caner Karahan
AMAhmet Mentese
Ahmet Mentese
ESElif Sag
Elif Sag
UCUmit Cobanoglu
Umit Cobanoglu
EEErol Erduran
Erol Erduran
Cakir M, et al. Gut Liver. 2012 Jan;6(1):92-97. http://dx.doi.org/10.5009/gnl.2012.6.1.92